Evidence map›Paper›PMID 27609517›Full record

ArticleThe Journal of biological chemistry2016

TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)346, a Regulatory Site of Syk.

Kevin Reppschläger, Jeanne Gosselin, Carol A Dangelmaier, Dafydd H Thomas, Nick Carpino, Steven E McKenzie, Satya P Kunapuli, Alexander Y Tsygankov

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. TULA Proteins in Men, Mice, Hens, and Lice: Welcome to the Family.International journal of molecular sciences · 2023
    Review
  7. The Sts Proteins: Modulators of Host Immunity.International journal of molecular sciences · 2023
    Review
  8. TULA-Family Regulators of Platelet Activation.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Feedback Regulation of Syk by Protein Kinase C in Human Platelets.International journal of molecular sciences · 2019
    Article
  13. Article
  14. Article
  15. TULA-2 Deficiency Enhances Platelet Functional Responses to CLEC-2 Agonists.TH open : companion journal to thrombosis and haemostasis · 2018
    Article
  16. Article
  17. Platelet Signaling Pathways and New Inhibitors.Arteriosclerosis, thrombosis, and vascular biology · 2018
    Review
  18. Article
  19. Article
  20. Modulating Host Signaling Pathways to Promote Resistance to Infection byFrontiers in cellular and infection microbiology · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Kevin ReppschlägerFrom the Departments of Microbiology and Immunology and.
Jeanne GosselinFrom the Departments of Microbiology and Immunology and.
Carol A Dangelmaierthe Sol Sherry Thrombosis Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania 19140.
Dafydd H Thomasthe Sol Sherry Thrombosis Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania 19140.
Nick Carpinothe Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York 11794.
Steven E McKenziethe Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
Satya P Kunapulithe Sol Sherry Thrombosis Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania 19140.
Alexander Y TsygankovFrom the Departments of Microbiology and Immunology and tsygan@temple.edu.
Temple University · USStony Brook University · USThomas Jefferson University · USUniversität Greifswald · DE

Funding

Protein CoreP01HL110860 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI PONCZ, MORTIMER · 2012 to 2016
$11.4M
Functional PKC Isoforms in PlateletsR01HL093231 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KUNAPULI, SATYA P. · 2009 to 2017
$3.6M
Regulation and function of PDK1-Akt-Pyk2 axis in plateletsR01HL118593 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KUNAPULI, SATYA P. · 2013 to 2016
$1.9M
NHLBI NIH HHS P01 HL110860NHLBI NIH HHS R01 HL093231NHLBI NIH HHS R01 HL118593
6 · The paper itself

Abstract

Protein-tyrosine phosphatase TULA-2 has been shown to regulate receptor signaling in several cell types, including platelets. Platelets are critical for maintaining vascular integrity; this function is mediated by platelet aggregation in response to recognition of the exposed basement membrane collagen by the GPVI receptor, which is non-covalently associated with the signal-transducing FcRγ polypeptide chain. Our previous studies suggested that TULA-2 plays an important role in negatively regulating signaling through GPVI-FcRγ and indicated that the tyrosine-protein kinase Syk is a key target of the regulatory action of TULA-2 in platelets. However, the molecular basis of the down-regulatory effect of TULA-2 on Syk activation via FcRγ remained unclear. In this study, we demonstrate that suppression of Syk activation by TULA-2 is mediated, to a substantial degree, by dephosphorylation of Tyr(P)

Indexed as

AnimalsBlood PlateletsMiceMice, Mutant StrainsPhosphorylationPlatelet Membrane GlycoproteinsProtein Tyrosine PhosphatasesSyk KinasePlatelet Membrane Glycoproteinsplatelet membrane glycoprotein VIProtein Tyrosine PhosphatasesSyk KinaseSyk protein, mouseTULA-2 protein, mouseGPVI receptorITAMplateletprotein phosphorylationsignalingspleen tyrosine kinase (Syk)TULA-2tyrosine-protein kinase (tyrosine kinase)tyrosine-protein phosphatase (tyrosine phosphatase)

Identifiers

PMID27609517
PMCPMC5077183
OpenAlexW2514074151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.